cell therapy

Vision loss biotech Aurion Biotech files for a $100 million IPO
Renaissance Capital
Mon, 01/27/25 - 11:29 am
Aurion Biotech
cell therapy
IPOs
vision loss
5 questions facing emerging biotech in 2025
BioPharma Dive
Tue, 01/14/25 - 11:22 am
biotech
funding
China
IPOs
cell therapy
gene therapy
M&A
JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson's trial
Fierce Biotech
Mon, 01/13/25 - 11:13 am
Bayer
JPMHC 2025
cell therapy
Parkinson's Disease
clinical trials
Sana’s cell therapy may be ‘transformative cure’ for type 1 diabetes: analysts
Fierce Biotech
Wed, 01/8/25 - 11:29 am
Sana Biotechnology
cell therapy
type 1 diabetes
UP421
Galapagos unveils plan to split, hiving off its drugs unit
Pharmaphorum
Wed, 01/8/25 - 11:13 am
Galapagos
restructuring
cell therapy
BrainChild Bio advances development of CAR T therapy for pediatric brain tumors
Biopharma Reporter
Tue, 01/7/25 - 11:21 am
BrainChild Bio
cell therapy
CAR-T
pediatric
FDA
brain tumors
FDA approves Mesoblast's cell therapy for graft-versus-host disease
Investing.com
Wed, 12/18/24 - 07:52 pm
FDA
Mesoblast
cell therapy
graft vs host disease
Ryoncil
Roche said it didn’t want to buy Poseida last year: A look at how the $1.5B buyout came to be
Fierce Biotech
Tue, 12/10/24 - 10:00 pm
Roche
Poseida Therapeutics
M&A
cell therapy
Protara shares spike after cell therapy shows high response rate, no severe side effects in bladder cancer trial
Fierce Biotech
Fri, 12/6/24 - 09:44 am
Protara Therapeutics
cell therapy
bladder cancer
clinical trials
Roche to buy cell therapy developer Poseida for $1B
BioPharma Dive
Tue, 11/26/24 - 11:24 am
Roche
Poseida Therapeutics
M&A
cell therapy
cancer
FDA shares additional draft guidance on cell and gene therapy
Clinical Trials Arena
Wed, 11/20/24 - 11:20 am
FDA
regulatory
gene therapy
cell therapy
CSL Behring shuts down California cell and gene therapy R&D site amid group pivot
Fierce Biotech
Mon, 11/18/24 - 11:27 am
CSL Behring
California
gene therapy
cell therapy
R&D
MD Anderson Cancer Center unveils cell therapy research institute that will work with biotech, pharma
Fierce Biotech
Mon, 11/11/24 - 06:29 pm
R&D
cell therapy
MD Anderson Cancer Center
Texas
Capricor cell therapy improves cardiac and upper limb function in phase 2 Duchenne muscular dystrophy victory lap
Fierce Biotech
Sun, 10/13/24 - 11:27 am
Capricor
DMD
clinical trials
cell therapy
Duchenne Muscular Dystrophy
deramiocel
Astellas unveils new Japan site for cell therapy research arm Universal Cells, transferring 12 roles overseas
Fierce Biotech
Wed, 10/9/24 - 09:07 pm
Astellas
Japan
cell therapy
Universal Cell
Legend set to open Philadelphia cell therapy R&D site next year
Fierce Biotech
Thu, 10/3/24 - 10:12 am
Legene Biotech
cell therapy
R&D
Pennsylvania
Philadelphia
Zephyrm rides IPO updraft toward Hong Kong listing, seeking cash for phase 3 cell therapy trials
Fierce Biotech
Wed, 10/2/24 - 10:40 am
Zephyrm Bioscience
Hong Kong
IPOs
cell therapy
graft vs host disease
After scoring a first for an off-the-shelf CAR-T, can Atara maintain momentum?
Pharma Voice
Mon, 09/30/24 - 09:17 am
Atara Biotherapeutics
CAR-T
cell therapy
Tab-cel
2seventy Bio stops enrolling patients in blood cancer therapy study
Reuters
Wed, 09/25/24 - 11:56 am
2seventy bio
Bristol Myers Squibb
Multiple Myeloma
cell therapy
Abecma
clinical trials
Aurion launches eye disease cell therapy in its first market
Pharmaphorum
Wed, 09/25/24 - 11:42 am
Aurion
Vyznova
bullous keratopathy
cell therapy
Japan

Pages